Laman UtamaABUS • NASDAQ
add
Arbutus Biopharma Corp
Tutup sebelumnya
$4.50
Julat hari
$4.47 - $4.62
Julat tahun
$2.71 - $5.10
Permodalan pasaran
883.56J USD
Bilangan Purata
2.67J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.05J | -33.23% |
Perbelanjaan pengendalian | 3.69J | -21.71% |
Pendapatan bersih | -3.76J | 70.03% |
Margin untung bersih | -357.37 | 55.11% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -7.63J | 34.28% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 91.47J | -25.40% |
Jumlah aset | 94.62J | -28.16% |
Jumlah liabiliti | 18.04J | -47.46% |
Jumlah ekuiti | 76.58J | — |
Syer tertunggak | 195.48J | — |
Harga kepada buku | 11.25 | — |
Pulangan pada aset | -19.87% | — |
Pulangan pada modal | -23.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -3.76J | 70.03% |
Tunai daripada operasi | -4.68J | 54.63% |
Tunai daripada pelaburan | -1.36J | -110.15% |
Tunai daripada pembiayaan | 1.64J | 15.41% |
Perubahan bersih dalam tunai | -4.40J | -198.13% |
Aliran tunai bebas | -1.95J | 77.37% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
19
